ArticleBioengineering (Basel, Switzerland)2026
Women's Health Wearables: From Continuous Signals to Actionable Digital Phenotypes Across the Reproductive Lifespan.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wearable technologies are reshaping women's health by extending observation beyond episodic clinical encounters into daily life. Across the reproductive lifespan, they can capture physiological, behavioral, symptom, and functional trajectories that are often missed in routine care. Yet more data do not automatically translate into better care. Clinical value depends on whether multimodal signals can be modeled and interpreted in relation to reproductive biology, temporal change, and meaningful clinical or functional endpoints. In this perspective, we examine how women's health wearables can move beyond consumer tracking toward validated digital phenotyping across menstruation, fertility, pregnancy, postpartum recovery, and menopause. We propose a four-layer framework spanning data capture, physiological domain mapping, computational phenotyping, and actionable translation. We then apply this framework across key reproductive life stages. Menstrual health and fertility applications illustrate the shift from calendar-based prediction toward physiological, metabolic, and hormone-aware monitoring. Pregnancy and postpartum applications highlight the need for safety-focused validation, maternal-infant risk awareness, and clinician-governed escalation pathways. Menopause and midlife health represent underdeveloped areas where longitudinal digital phenotyping may better capture vasomotor, sleep, mood, fatigue, and functional symptoms. Across these domains, we identify key barriers to translation, including limited hormone-linked validation, inconsistent evidence standards, underrepresentation of diverse populations, privacy risks, algorithmic bias, and weak workflow integration. By organizing wearable-derived signals across reproductive life stages and identifying major translational barriers, this perspective provides a roadmap toward biologically grounded, equitable, and clinically actionable digital phenotyping for women's health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.